Position in MDXG
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$946,172
-$27,775 QoQ
Shares Held
245,759
-0.3% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 226 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 30%
Shared 0%
None 70%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fisher Asset Management, LLC holds $807,507,065 across 59 Biotechnology names. MDXG ranks #44 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
957,691 | $78,061,393 | |
| 2 | RCUS |
Arcus Biosciences, Inc.
|
2,139,396 | $65,957,578 | |
| 3 | CYTK |
Cytokinetics Inc
|
743,697 | $63,355,547 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
2,414,162 | $62,092,246 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
207,693 | $38,896,745 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
121,440 | $38,385,969 | |
| 7 | CLDX |
Celldex Therapeutics, Inc.
|
985,677 | $36,677,041 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
427,713 | $33,477,096 |
All Filings in MDXG
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $946,172 | 245,759 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $973,947 | 246,569 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,663,788 | 245,759 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,816,489 | 260,242 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,668,042 | 273,002 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,074,815 | 273,002 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,626,279 | 273,002 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $1,725,607 | 291,981 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,188,701 | 315,830 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,552,211 | 331,456 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $3,037,664 | 346,370 | Shares | Defined | 2024-03-05 | |
| 2023-09-30 | $2,880,920 | 395,188 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,074,839 | 465,180 | Shares | Sole | 2023-12-12 | |
| 2023-03-31 | $1,760,968 | 516,413 | Shares | Sole | 2023-12-12 | |
| 2022-12-31 | $1,679,114 | 603,998 | Shares | Defined | 2023-02-03 | |
| 2022-09-30 | $1,228,477 | 428,041 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $1,485,302 | 428,041 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $1,755,374 | 372,691 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $1,449,962 | 240,060 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $577,560 | 95,307 | Shares | Defined | 2021-10-26 | |
| No filing history on record for this holder in this stock. | ||||||